Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewPhotography of animal experimentation in Spain: the foundation of health advancements unde...
On the occasion of the International Day of the Laboratory Animal, we analyze the legislative and utilization situation of animal experimentation, essential for progress in fields such as oncology
-
NewBiofertilizers and botanical-origin activators are among the biotechnology solutions to ni...
Nitrite water pollution has been a pending issue in Spain for several years. The European Commission already warned about this problem in November 2018, and now, it has been condemned by the European
-
NewQuibim organizes two webinars focused on early detection of prostate cancer and AI
Quibim has held two webinars on the early detection of prostate cancer and the applications of artificial intelligence at clinical levels.
-
NewBCN HEALTH publishes a study evaluating the hospital incidence and medical costs of congen...
BCN HEALTH has published the study ‘Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study’ in the journal ‘Expert Review of Pharmacoeconomics & Outcomes
-
NewVaxdyn and the University of Latvia have obtained funding from the EUROSTARS program to pr...
They receive a grant of half a million euros to prepare the clinical and commercial strategy for vaccination against Klebsiella pneumoniae and Acinetobacter baumannii bacteria.
-
New#AseBioID24 | "These ecosystem events are the best way to develop relationships with inves...
We analyze the challenges and opportunities of the biotechnology sector in areas such as financing and driving its disruptive innovations, led by Antonio López, CEO of SILO, Silver Sponsor of the
-
NewORYZON secures another important patent for its lead CNS asset, vafidemstat
Has received “Intention to Grant” from the European Patent Office.
-
-
NewThe R&D investment of Spanish biotechnology increased by 13% in 2022, surpassing 2.5 billi...
According to the INE, when exclusively analyzing the figures in Companies, R&D investment has increased by 18% compared to 2021: 1.223 billion euros compared to 1.038 billion euros, respectively.
-
-
New#NewAseBioMember | “AseBio is an important industry association in Spain, representing the...
Meet Owkin, our new member. We talked to its Francisco Miguel Torres, Partnerships Director, Southern Europe.
-
Press releaseAseBio launches the Food Innovation Working Group to boost the biotechnological potential ...
The Spanish agri-food sector has undeniable strategic value for the national economy due to its impact on GDP: Spain ranks as the eighth global agri-food power. Within AseBio, over 25% of our members
-
NewThe "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard...
Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally are biotechnological.
-
Press release
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard...
We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for the protection, development, and promotion of biotechnological innovation in
-
EventWebinar: Preparing for IVDR Clinical Performance Studies
The webinar will focu on the critical aspects of designing and conducting In Vitro Diagnostic (IVD) performance studies under the stringent requirements of the EU IVDR and ISO 20916.
-
NewBiotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di...
Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating symptoms once the diagnosis has been made.
-
Press release
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di...
Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000 individuals. Parkinson's is an extremely debilitating disease, there is no cure
-
EventAseBio Green Innovation Forum 2026
The sixth edition, organized by AseBio and the Salamanca City Council, will take place on April 21 at the Castilla y León Conference and Exhibition Centre.
-
EventWorld Orphan Drug Congress Europe
Strategy, Advocacy & Partnering for The Global Orphan Drug Industry.
-
New#NewAseBioMember | “AseBio is the perfect platform for company collaboration, research syn...
Meet Copal Scientific, our new member. We talked to its Mercedes Iriarte Cela, CEO.
-
New#NewAseBioMember | “AseBio represents a platform within the bioindustry ecosystem”
Meet Spinally Medical, our new member. We talked to its Carles García-Vitoria, Co-fundador & Chief Scientific Officer.
